Results 141 to 150 of about 1,588 (158)
Some of the next articles are maybe not open access.
Response to [Palmitoylethanolamide: one molecule, different formulations]
Psychiatry and Clinical Neurosciences, 2023Hossein Sanjari Moghaddam +1 more
openaire +2 more sources
Palmitoylethanolamide: A Potential Alternative to Cannabidiol
Journal of Dietary Supplements, 2023Paul Clayton
exaly
Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
International Journal of Molecular Sciences, 2021Alessio Filippo Peritore +2 more
exaly
Anticonvulsant Activity of N-Palmitoylethanolamide, a Putative Endocannabinoid, in Mice
Epilepsia, 2002Didier M Lambert, Severine Vandevoorde
exaly
Acute administration of palmitoylethanolamide: behavioural studies
2013N-palmitoylethanolamide (PEA), the amide of palmitic acid and ethanolamine, belongs to the family of lipidic mediators that includes endogenous ligands of peroxisome proliferator-activated receptor-alpha (PPAR-α). PEA is broadly demonstrated to possess effects on metabolism, feeding, inflammation and pain (Pistis and Melis, 2010).
MAMELI, ALESSANDRA +6 more
openaire +1 more source
The Palmitoylethanolamide and Oleamide Enigmas: Are These Two Fatty Acid Amides Cannabimimetic?
Current Medicinal Chemistry, 1999Didier M Lambert, Vincenzo Di Marzo
exaly